Help | RSS Feed

XTL Biopharmaceuticals Ltd. (NASD:XTLB) Seasonal Chart

XTL Biopharmaceuticals Ltd. (NASD:XTLB) Seasonality

XTLB Relative to the S&P 500
XTLB Relative to the S&P 500

XTLB Relative to the Sector
XTLB Relative to the Sector

Monthly Seasonal XTL Biopharmaceuticals Ltd. (NASD:XTLB)

Seasonal Chart Analysis

Analysis of the XTL Biopharmaceuticals Ltd. (NASD:XTLB) seasonal charts above shows that a Buy Date of May 10 and a Sell Date of August 1 has resulted in a geometric average return of 8.51% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 48.69% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore